Thumbnail
Access Restriction
Open

Author Klompenhouwer, Elisabeth G. ♦ Dresen, Raphaëla C. ♦ Verslype, Chris ♦ Laenen, Annouschka ♦ Hertogh, Gert De ♦ Deroose, Christophe M. ♦ Bonne, Lawrence ♦ Vandevaveye, Vincent ♦ Maleux, Geert
Source United States Department of Energy Office of Scientific and Technical Information
Content type Text
Language English
Subject Keyword RADIOLOGY AND NUCLEAR MEDICINE ♦ HEPATOMAS ♦ NMR IMAGING ♦ PATIENTS ♦ RADIOEMBOLIZATION ♦ REFRACTORIES ♦ YTTRIUM 90
Abstract IntroductionTransarterial chemoembolisation (TACE) is the most widely used locoregional treatment for patients with an unresectable hepatocellular carcinoma (HCC). Transarterial radioembolisation (TARE) with yttrium-90 containing microspheres is an emerging interventional treatment that could be complementary or an alternative to TACE.AimTo evaluate the safety and efficacy of TARE in patients with HCC who are refractory to TACE with drug-eluting beads (DEB-TACE).MethodsWe identified all patients who received TARE for HCC following one or more sessions of DEB-TACE in the period 2007–2016. Grade ≥3 adverse events were graded according to Common Terminology Criteria for Adverse events. Response on MRI was determined on MRI by modified RECIST. Overall survival was estimated using the Kaplan–Meier method and was determined from the first TACE and from the TARE procedure.ResultsA total of 30 patients were included. Patients had a mean of 1.7 TACE procedures (range 1–4) prior to TARE. Grade 3 adverse events following TARE included: fatigue (20%), bilirubin increase (10%), cholecystitis (3.3%) and a gastric ulcer (3.3%). Response on MRI was achieved in 36.7%. Three patients (10%) were downstaged within the Milan criteria and received liver transplantation. The median overall survival after first TACE was 32.3 months (17.2–42.1 95% CI). The median overall survival after TARE was 14.8 months (8.33–26.5 95% CI).ConclusionTARE is safe and can be effective in patients with an intermediate or advanced stage HCC who are refractory to TACE. This treatment strategy has the potential to downstage to liver transplantation.
ISSN 01741551
Educational Use Research
Learning Resource Type Article
Publisher Date 2017-12-15
Publisher Place United States
Journal Cardiovascular and Interventional Radiology
Volume Number 40
Issue Number 12


Open content in new tab

   Open content in new tab